Reisner, Colin <br/><br/>
Efficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe COPD.  [electronic resource] 

 -  International journal of chronic obstructive pulmonary disease  2018 
 - 1965-1977 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1178-2005 
<br/><br/><label>Standard No.: </label>10.2147/COPD.S166455  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Area Under Curve<br/>Bronchodilator Agents--administration & dosage<br/>Cross-Over Studies<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Forced Expiratory Volume<br/>Formoterol Fumarate--administration & dosage<br/>Glycopyrrolate--administration & dosage<br/>Humans<br/>Male<br/>Metered Dose Inhalers<br/>Middle Aged<br/>Muscarinic Antagonists--administration & dosage<br/>Nutrition Surveys<br/>Pulmonary Disease, Chronic Obstructive--drug therapy<br/>Reproducibility of Results<br/>Severity of Illness Index